Search | Clinical Trials Finder

ClinicalTrials.gov public records Last synced Sep 24, 2026, 3:52 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Showing 25–39 of 15 matching trials from the live ClinicalTrials.gov search.

Local D1 index available.

Filters: Condition: Postsurgical Analgesia Clear all

Conditions: Pain
Interventions: Saline Solution for Injection, Exparel; Drug
Lead sponsor: Maimonides Medical Center; Other
Eligibility: 35 Years to 75 Years · Female only
Enrollment: 60 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Brooklyn, New York

Conditions: Pain
Interventions: EXPAREL, Bupivacaine; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older · Male only
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 17
States / cities: Fremont, California • Loma Linda, California • Fort Lauderdale, Florida + 13 more

Conditions: Lower Extremity Fractures.
Interventions: Bupivacaine/Exparel; Drug
Lead sponsor: Broward Health; Other
Eligibility: 18 Years and older
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015
U.S. locations: 1
States / cities: Fort Lauderdale, Florida

Conditions: Pain, Postoperative, Hernia, Ventral, Abdominoplasty, Hysterectomy, Colectomy, Reduction Mammoplasty
Interventions: INL-001 (bupivacaine hydrochloride) implant; Combination Product
Lead sponsor: Innocoll; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 8
States / cities: Florence, Alabama • Sheffield, Alabama • Pasadena, California + 3 more

Conditions: Postsurgical Pain Management, Postsurgical Pain, Chronic, Opioid Use After Surgery
Interventions: TPS-Select, Pharmacologic Pain Management, Interventional Pain Procedures, Psychological Management and Pain Education, Physical Therapy; Device · Drug · Procedure + 1 more
Lead sponsor: University of California, San Francisco; Other
Eligibility: 18 Years and older
Enrollment: 126 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Bunionectomy, Hallux Valgus
Interventions: Bupivacaine liposome injectable suspension 266 mg, Bupivacaine HCl, Bupivacaine liposome injectable suspension 133 mg; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 185 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 7
States / cities: North Little Rock, Arkansas • Pasadena, California • Dayton, Ohio + 4 more

Conditions: Postoperative Pain Management
Interventions: Exparel, 0.5% Bupivacaine HCl; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 6 Years to 17 Years
Enrollment: 98 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 17
States / cities: Loma Linda, California • Sacramento, California • Stanford, California + 14 more

Conditions: Spinal Fusion, Pain Management
Interventions: EXPAREL; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 15 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 3
States / cities: Miami, Florida • Columbus, Ohio • Philadelphia, Pennsylvania

Conditions: Bunion
Interventions: Exparel Injectable Product, Bupivacaine; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 45 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: Bellaire, Texas

Conditions: Postoperative Pain Management
Interventions: Exparel; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 12 Years to 16 Years
Enrollment: 15 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Cleveland, Ohio

Conditions: Knee Osteoarthritis, Pain Management
Interventions: bupivacaine liposome injectable suspension, Bupivacaine Hydrochloride; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022
U.S. locations: 6
States / cities: Little Rock, Arkansas • Pasadena, California • Dayton, Ohio + 3 more

Conditions: Chronic Pain, Cesarean Section Complications, Postpartum
Interventions: Empowered Relief; Behavioral
Lead sponsor: Stanford University; Other
Eligibility: 18 Years and older · Female only
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Postoperative Pain Management
Interventions: EXPAREL and Bupivacaine, Standard of Care; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 65 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2020
U.S. locations: 12
States / cities: New Haven, Connecticut • Boca Raton, Florida • Miami, Florida + 9 more

Conditions: Pain
Interventions: bupivacaine liposome injectable suspension, Placebo; Drug
Lead sponsor: Pacira Pharmaceuticals, Inc; Industry
Eligibility: 18 Years and older
Enrollment: 156 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2017
U.S. locations: 17
States / cities: Mobile, Alabama • Englewood, Colorado • Miami, Florida + 12 more

Conditions: Postoperative Pain
Interventions: TLC590, Liposomal Bupivacaine, Saline Placebo; Drug
Lead sponsor: TLC Biopharmaceuticals, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 304 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2026
U.S. locations: 4
States / cities: Miami, Florida • Bellaire, Texas • Houston, Texas + 1 more

Search by objective public record fields.

EXPAREL for Minimally Invasive Supracervical Hysterectomies

Local Infiltration Analgesia With and Without EXPAREL Following Total Knee Arthroplasty

A Study of Postsurgical Pain Control for Lower Extremity Fractures

An Open-label Safety and Pharmacokinetic Study of INL-001 in Adults Following Various Open Soft-Tissue Surgeries

An Artificial Intelligence Driven Approach to Optimize Patient Selection for a Transitional Pain Service

Phase 3, Sciatic Nerve Block With EXPAREL for Subjects Undergoing Bunionectomy

Multicenter Study for Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

PK Study of EXPAREL in Subjects Undergoing Open Spinal Fusion or Reconstructive Surgery

Study to Evaluate the Pharmacokinetics, Pharmacodynamics and Safety, of EXPAREL Administered as Sciatic Nerve Block (In Popliteal Fossa), for Postsurgical Analgesia in Subjects Undergoing Bunionectomy

Study in Pediatric Subjects Evaluating Pharmacokinetics and Safety of EXPAREL

Phase 3 Adductor Canal Block With EXPAREL in Subjects Undergoing Primary Unilateral Total Knee Arthroplasty

Reducing Chronic Pain Following Cesarean Delivery

Phase 4 Study in Adult Subjects Undergoing Posterior Lumbar Spine Surgeries

Efficacy, Safety, and Pharmacokinetics of Brachial Plexus Block With EXPAREL in Shoulder Surgery

A Study of TLC590 for Postsurgical Pain Following Bunionectomy